Volume 16, Number 11—November 2010
CME ACTIVITY - Research
Enhanced Surveillance of Coccidioidomycosis, Arizona, USA, 2007–2008
, Shoana M. Anderson, Sara B. Imholte, Laura M. Erhart, Sanny Chen, Benjamin J. Park, Cara Christ, Kenneth K. Komatsu, Tom M. Chiller, and Rebecca H. Sunenshine
Table 2
Clinical and behavioral characteristics of enhanced surveillance coccidioidomycosis patients, Arizona, USA, January 2007–February 2008*
| Characteristic | No. (%) |
|---|---|
| Coexisting condition | |
| Heart disease | 62 (13) |
| Lung disease | 90 (18) |
| Asthma requiring inhaler | 47 (10) |
| COPD or emphysema | 27 (6) |
| Other | 29 (6) |
| Malignancy | 70 (14) |
| Transplant | 11 (2) |
| HIV | 9 (2) |
| Diabetes mellitus | 72 (15) |
| None |
164 (33) |
| Immunosuppression† |
97 (20) |
| Smoker | |
| Active | 76 (15) |
| Past | 203 (41) |
| Never | 202 (41) |
| Unknown |
12 (2) |
| Site of infection, n = 282 | |
| Primary pulmonary‡ | 240 (85) |
| Disseminated§ | 42 (15) |
*N = 493. COPD, chronic obstructive pulmonary disease.
†Immunosuppression is defined as having HIV/AIDS, a solid-organ transplant, or a bone marrow transplant or taking immunosuppressive medications. Immunosuppressive medications refer to medications that suppress the immune system and include chemotherapy medications such as steroids, prednisone, dexamethasone, infliximab, or interferon, as self-reported by patients.
‡Primary pulmonary infection is defined as the lungs being the only site of infection, as self-reported by patients.
§Disseminated infection is defined as infection spread to other parts of the body, including the central nervous system, bone, and entire body, as self-reported by patients.